On the basis of these expression patterns, specific PDE7 inhibitors are suggested as promising approach for treatment of inflammatory and neurological disorders associated with T-cell activation and function [116], Parkinson’s disease [117], and addiction [118,119,120]. This evidence concerns the gene PDE7A and nervous system disorder.